2010 Fiscal Year Final Research Report
Treatment using bisphosphonate for malignant bone and soft tissue tumors
Project/Area Number |
20591764
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Orthopaedic surgery
|
Research Institution | Kyoto Prefectural University of Medicine |
Principal Investigator |
MURATA Hiroaki Kyoto Prefectural University of Medicine, 医学研究科, 客員講師 (90360031)
|
Co-Investigator(Kenkyū-buntansha) |
KIMURA SHINYA 佐賀大学, 医学部, 教授 (80359794)
|
Project Period (FY) |
2008 – 2010
|
Keywords | 悪性骨腫瘍 / 悪性軟部腫瘍 / ビスホスフォネート / 癌 |
Research Abstract |
The lower dose of third generation bisphosphonates (BPs) significantly prevented lung metastasis for the in vivo effects of BPs, although the higher dose of BPs was required to inhibit the growth of osteosarcoma cells at the primary site. In addition, BPs inhibited the production of vascular endothelial growth factor and reduced the migration, adhesion, and invasiveness of osteosarcoma cells in vitro. Combinationtherapy using BPs and radiation augmented the antitumor effects. From the results ofantitumor effects of BPs against fibrosarcoma cells, BPs arrested the cell cycle in the S phases, inhibited cell proliferation, and induced the apoptosis of their cells. Moreover, BPs augmented the effect of antitumor agents when administered concurrently with them in human fibrosarcoma cells.
|
Research Products
(14 results)
-
[Journal Article] Zoledronic acid inhibits proliferation of human fibrosarcoma cells with induction of apoptosis, and shows combined effects with other anticancer agents.2010
Author(s)
Koto K, Murata H, Kimura S, Horie N, Matsui T, Nishigaki Y, Ryu K, Sakabe T, Itoi M, Ashihara E, Maekawa T, Fushiki S, Kubo T.
-
Journal Title
Oncol Rep 24
Pages: 233-239
Peer Reviewed
-
[Journal Article] Combined effects of bisphosphonate and radiation on osteosarcoma cells.2010
Author(s)
Ryu K, Murata H, Koto K, Horie N, Matsui T, Nishigaki Y, Sakabe T, Takeshita H, Itoi M, Kimura S, Ashihara E, Maekawa T, Fushiki S, Kubo T.
-
Journal Title
Anticancer Res 30
Pages: 2713-2720
Peer Reviewed
-
[Journal Article] Clinically relevant dose of zoledronic acid inhibits spontaneous lung metastasis in a murine osteosarcoma model.2009
Author(s)
Koto K, Horie N, Kimura S, Murata H, Sakabe T, Matsui T, Watanabe M, Adachi S, Maekawa T, Fushiki S, Kubo T.
-
Journal Title
Cancer Lett 274
Pages: 271-278
Peer Reviewed
-
[Presentation] Combined effects of a third-generation bisphosphonate and radiation against murine osteosarcoma.2010
Author(s)
村田博昭, 劉和輝, 小藤和孝, 堀江直行, 小藤和孝, 村田博昭, 坂部智哉, 劉和輝, 西垣泰典, 松井隆明, 坂部智哉, 西垣泰典, 久保俊一
Organizer
8th Asis Pacific Musculoskeletal Tumor Society Meeting
Year and Date
20100224-20100227
-
[Presentation] 骨軟部肉腫細胞株に対する第3世代Bisphosphonate 含有ハイドロキシアパタイトの抗腫瘍効果の検討2010
Author(s)
小藤和孝, 村田博昭, 坂部智哉, 劉和輝, 松井隆明, 堀江直行, 澤井泰志, 芦原英司, 伏木信次, 前川平, 久保俊一
Organizer
第25回日本整形外科学会基礎学術集会
Year and Date
2010-10-14
-
-
-
-
-
[Presentation] ヒト軟部肉腫細胞株に対する第3世代Bisphosphonate と放射線の併用効果に関する検討2009
Author(s)
小藤和孝, 村田博昭, 坂部智哉, 劉和輝, 西垣泰典, 松井隆明, 堀江直行, 伏木信次, 木村晋也, 前川平, 久保俊一
Organizer
第24回日本整形外科学会基礎学術集会
Year and Date
2009-11-06
-
-
-
-